Global Antibiotics Market - Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • Jan 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Antibiotics Market By Indication (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections and Others), By Drug Class  (Beta Lactam & Beta Lactamase Inhibitors, Quinolone, Macrolide, Others), By Drug Origin (Natural, Semisynthetic, Synthetic), By Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), By Route of Administration (Oral, Parenteral, Topical, Others), By End Users (Hospitals, Homecare, Specialty Clinics, Others), By  Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy Others), By Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa), Market Trends and Forecast to 2027

Market Analysis and Insights: Global Antibiotics Market

Antibiotics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the infectious diseases worldwide and recently approval of the drug are the factors responsible for the growth of this market.

Increasing number of patients suffering from infectious diseases drives the growth of antibiotics market. Ongoing clinical trials are being conducted by many pharmaceuticals companies will also boost up the antibiotics market growth. In addition, advances in antibiotics drugs and novel combination therapies to treat antibiotic-resistant microbial infections can advance the treatment landscape can also be a factors that drive the growth this market in the above forecasted period. Furthermore, a special designation from the regulatory authority to various potential pharmaceuticals companies is one of the factors which are expected to drive the market growth.

Antibiotics are also known as an antibacterial agent that has the ability to destroy or slow down the growth of bacteria and are widely used for the treatment and prevention of diseases caused by bacteria. According to the statistics published in our World in Data 2016. It is estimated that approximately 229.96 million patients affected with diarrhea and infectious disease. Surge volume of patients suffering from infectious diseases and development in newer diagnostics devices are considered as key factors that lead the growth of this market.

Antibiotics market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Antibiotics Market

Global Antibiotics Market Scope and Market Size

The antibiotics market is segmented on the basis of indication, drug class, drug origin, spectrum of activity, route of administration, end-users and distribution channel.

  • On the basis of indication, the antibiotics market is segmented into urinary tract infection, intra-abdominal infections, blood stream infections, clostridium difficile infections and others.
  • The drug class segment for antibiotics market includes beta lactam & beta lactamase inhibitors, quinolone, macrolide and others.
  • On the basis of drug origin, the antibiotics market is segmented into natural, semisynthetic, synthetic.
  • Antibiotics market is segmented into broad-spectrum antibiotic and narrow-spectrum antibiotic on the basis of spectrum of activity.
  • Route of administration segment of antibiotics market is segmented into oral, parenteral, topical and others.
  • On the basis of end-users, the antibiotics market is segmented into hospitals, homecare, specialty clinics and others
  • Antibiotics market has also been segmented based on the distribution channel into hospital pharmacy, online pharmacy, retail pharmacy others.

Antibiotics Market Country Level Analysis

Antibiotics market is analyzed and market size information is provided by country, indication, drug class, drug origin, spectrum of activity, route of administration, end-users and distribution channel as referenced above.

The countries covered in the antibiotics market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

AsiaPacific is likely to dominate over the upcoming years for the antibiotics market due to larger population, high prevalence cases of infectious disease and lenient regulation on antibiotics drugs. North America is anticipated to have bright growth prospects in the coming years with escalating prevalence of infectious disease while Europe is expected to hold substantial growth due to the focus of various established market players to expand their presence in this particular region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Global Antibiotics market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Antibiotics Market Share Analysis

Antibiotics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to antibiotics market.

The major players covered in the antibiotics market are Johnson & Johnson Services, Inc, Sanofi, Bayer AG, Abbott, F. Hoffmann-La Roche Ltd, Melinta Therapeutics, INC, Merck & Co., Inc., Allergan, Pfizer Inc, Novartis AG, LG Chem, Mylan N.V, Lupin, Hitech, Amneal Pharmaceuticals LLC, Zydus Cadila, Bausch Health, Teva Pharmaceutical Industries Ltd, Akron Incorporated, KYORIN Holdings, Inc, MerLion Pharmaceuticals GmbH, Wockhardt and others.

Key Market Development

In January 2018, Melinta Therapeutics, Inc launched Baxdela (delafloxacin), an oral fluoroquinolone for the treatment of acute bacterial skin and skin structure infections (ABSSSI) which is caused by designated susceptible bacteria. The launch of Baxdela provides new treatment option as well as expands company’s portfolio in the infection therapeutics area.

Customization Available : Global Antibiotics Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE